Your browser doesn't support javascript.
loading
Risk factors and incidence of cytomegalovirus viremia and disease in pediatric patients with allogeneic hematopoietic stem cell transplantation: An 8-year single-center experience in Latin America.
Aristizabal, Ana M; Perez, Paola; Patiño Niño, Jaime A; Franco, Alexis; Tarapues, Eliana Manzi; Beltran, Estefania; Medina, Diego.
Afiliação
  • Aristizabal AM; Facultad de ciencias de la salud, Universidad Icesi, Cali, Colombia.
  • Perez P; Departamento Materno-Infantil, Fundación Valle del Lili, Cali, Colombia.
  • Patiño Niño JA; Fundación Valle del Lili, Centro de Investigaciones Clínicas, Cali, Colombia.
  • Franco A; Facultad de ciencias de la salud, Universidad Icesi, Cali, Colombia.
  • Tarapues EM; Fundación Valle del Lili, Centro de Investigaciones Clínicas, Cali, Colombia.
  • Beltran E; Departamento Materno-Infantil, Fundación Valle del Lili, Grupo de Infectología Pediátrica, Cali, Colombia.
  • Medina D; Facultad de ciencias de la salud, Universidad Icesi, Cali, Colombia.
Pediatr Transplant ; 26(6): e14324, 2022 09.
Article em En | MEDLINE | ID: mdl-35647735
BACKGROUND: Cytomegalovirus infection represents a significant cause of morbidity and mortality after hematopoietic stem cell transplantation. This study aimed to evaluate the incidence of viremia and disease due to cytomegalovirus and the risk factors in pediatric patients with hematopoietic stem cell transplantation in our institution. METHODS: This was a retrospective cohort of patients under 19 years of age who underwent allogeneic hematopoietic stem cell transplantation due to any indication between 2012 and 2019. The analysis included the diagnosis of cytomegalovirus viremia or disease during post-transplant follow-up, evaluation of risk factors, and outcomes. The statistical analysis included univariate and multivariate analyses, and the cumulative incidence of cytomegalovirus viremia was determined by the Kaplan-Meier method using STATA 14 statistical software. RESULTS: A total of 182 transplants were included. At 100 days, the cumulative incidence of cytomegalovirus viremia was 70.5%, and that of cytomegalovirus disease was 4.7%. Overall survival at 2 years was 74%, and event-free survival was 64%. The remaining demographic characteristics were not predictors of infection. There was no association between viremia and relapse or survival of the patients. Higher mortality was noted in cytomegalovirus disease. CONCLUSIONS: During the study period, the incidence of cytomegalovirus disease was similar to that of other pediatric reports, but the incidence of viremia was higher. Pre-emptive therapy has diminished disease rates and death due to infection. Viral load cutoff points should be standardized to guide treatment and avoid myelotoxicity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Pediatr Transplant Assunto da revista: PEDIATRIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Pediatr Transplant Assunto da revista: PEDIATRIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Dinamarca